vTv Therapeutics Inc (VTVT) Stock Analysis

vTv Therapeutics Inc (VTVT) is a publicly traded company in the HEALTHCARE sector. It trades at $33.00, carries a market capitalization of $135.10M. This page summarizes the public market data, fundamentals, and frequently asked questions for VTVT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

vTv Therapeutics Inc currently has a Neutral sentiment score of -0.09.

About vTv Therapeutics Inc

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative orally administered small molecule therapies to meet significant unmet medical needs. The company's promising pipeline is primarily focused on treatments for central nervous system disorders and metabolic diseases, underscoring its commitment to advancing healthcare solutions. With a highly experienced management team and strategic collaborations, vTv Therapeutics is st...

GNG Research Analysis

GNG Research scores vTv Therapeutics Inc (VTVT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VTVT.

Frequently Asked Questions

Does VTVT pay dividends?

vTv Therapeutics Inc (VTVT) does not currently pay a regular dividend.

What is VTVT's market cap?

vTv Therapeutics Inc (VTVT) has a market capitalization of $135.10M with a current stock price of $33.00.